Your COVID-19 immunity could last 'possibly a lifetime'


Two new studies suggest COVID-19 immunity following infection could last a year, or "possibly a lifetime, improving over time especially following vaccination" The New York Times reported on Wednesday, hopefully allaying "lingering fears that protection against the virus will be short-lived."
When taken together, the studies suggest most (but not all) vaccinated individuals who were previously infected with COVID-19 "will not need boosters," wrote the Times. Those who were vaccinated without having previously contracted the virus will likely need the extra dose. Experts expect immunity in these individuals to "play out very differently," as "immune memory" may look different following vaccination compared to natural infection.
"The papers are consistent with the growing body of literature that suggests that immunity elicited by infection and vaccination for SARS-CoV-2 appears to be long-lived," said Scott Hensley, an immunologist not involved in the studies. Dr. Michel Nussenzweig, a researcher for one of the studies, added he expects antibodies in those who were previously infected and later vaccinated to "last for a long time."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Results, however, also underscore the idea that previous infection is not enough to protect individuals long-term on its own — even those who have recovered should be vaccinated, wrote the Times. Read more at The New York Times.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
The end of ‘golden ticket’ asylum rights
The Explainer Refugees lose automatic right to bring family over and must ‘earn’ indefinite right to remain
-
Grecotel Luxme Dama Dama: Greek luxury with a breezy beach vibe
The Week Recommends Rhodes is reimagined in this refined and relaxed resort
-
Sudoku medium: October 8, 2025
The Week's daily medium sudoku puzzle
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts